Search research articles
Contact Us
Filters
Showing results (81-90 of 304) with videos related to
Page
of 31
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein Seeds
Sandrina Weber, Carly M Farris, Yihua Ma, et al.
International Journal of Molecular Sciences
|
December 11, 2025
Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's Disease
Mary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI
Irene Litvan, Dag Aarsland, Charles H Adler, et al.
Plos One
|
October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease
Michael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Journal of Neuroscience Research
|
October 28, 2009
Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases
Sandra Ebert, Miriam Goos, Lena Rollwagen, et al.
Proteomics. Clinical Applications
|
December 8, 2010
CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction
Mirko Bibl, Piotr Lewczuk, Hermann Esselmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2017
Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
Jean-Pierre Trezzi, Sara Galozzi, Christian Jaeger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 7, 2011
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease
Brit Mollenhauer, Hermann Esselmann, Sigrun Roeber, et al.
Plos One
|
November 30, 2018
Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research
Lukas M Schilde, Steffen Kösters, Simone Steinbach, et al.
Proteomics
|
September 25, 2008
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin, Olaf Jahn, Petra Steinacker, et al.
Page
of 31
Search research articles
Search
Showing results (81-90 of 304) with videos related to
Sort By:
Page
of 31
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 9, 2025
Anosmia and Upper Limb Rigidity-A Potential Phenotype of Idiopathic Normal Pressure Hydrocephalus with Cerebrospinal Fluid α-Synuclein Seeds
Sandrina Weber, Carly M Farris, Yihua Ma, et al.
International Journal of Molecular Sciences
|
December 11, 2025
Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's Disease
Mary Xylaki, Avika Chopra, Yevheniia Kyriachenko, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 11, 2011
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI
Irene Litvan, Dag Aarsland, Charles H Adler, et al.
Plos One
|
October 7, 2021
Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease
Michael Bartl, Mohammed Dakna, Douglas Galasko, et al.
Journal of Neuroscience Research
|
October 28, 2009
Recurrent systemic infections with Streptococcus pneumoniae do not aggravate the course of experimental neurodegenerative diseases
Sandra Ebert, Miriam Goos, Lena Rollwagen, et al.
Proteomics. Clinical Applications
|
December 8, 2010
CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction
Mirko Bibl, Piotr Lewczuk, Hermann Esselmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 27, 2017
Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
Jean-Pierre Trezzi, Sara Galozzi, Christian Jaeger, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 7, 2011
Different CSF β-amyloid processing in Alzheimer's and Creutzfeldt-Jakob disease
Brit Mollenhauer, Hermann Esselmann, Sigrun Roeber, et al.
Plos One
|
November 30, 2018
Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research
Lukas M Schilde, Steffen Kösters, Simone Steinbach, et al.
Proteomics
|
September 25, 2008
Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease
Peter Brechlin, Olaf Jahn, Petra Steinacker, et al.
Page
of 31